RBC Bioscience
M&A
STATUS
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Manufacturers of nucleic acid extraction equipment. The company's nucleic acid extraction equipment include nudeic acid extractor, HIT competent cells, polymerases and cloring system, enabling the international molecular diagnostic markets for transformation, cloning, genomics and proteomics research.
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Discovery Tools (Healthcare)
Parent Company
Primary Office
- 3F., No.132, Ln. 235, Baoqiao Road
- Xindian Dist
- New Taipei, 231-45
- Taiwan
+886 02 0000 0000
RBC Bioscience Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore RBC Bioscience‘s full profile, request access.
Request full access to PitchBook